Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
about
Nicotine replacement therapy for smoking cessationInterventions for preventing weight gain after smoking cessationNicotine replacement therapy for smoking cessationMecamylamine (Inversine): an old antihypertensive with new research directionsMecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disordersNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?The duration of nicotine withdrawal-associated deficits in contextual fear conditioning parallels changes in hippocampal high affinity nicotinic acetylcholine receptor upregulation.Nicotine response genetics in the zebrafish.Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptors.Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.Neuroadaptation in nicotine addiction: update on the sensitization-homeostasis modelMecamylamine (a nicotine antagonist) for smoking cessation.Nicotinic receptor antagonists as treatments for nicotine abuse.Nicotine patch preloading for smoking cessation (the preloading trial): study protocol for a randomized controlled trial.Preclinical Pharmacology, Efficacy and Safety of Varenicline in Smoking Cessation and Clinical Utility in High Risk Patients.Smoking cessation therapy with vareniclineTargeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependenceEffects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.Nicotine dependence and its risk factors among users of veterans health services, 2008-2009.Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors.Clinical neuropharmacology of drugs of abuse: a comparison of drug-discrimination and subject-report measures.3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of human α4β2 neuronal nicotinic acetylcholine receptors.Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonistTranslating laboratory discovery to the clinic: from nicotine and mecamylamine to Tourette's, depression, and beyond.Defining the putative inhibitory site for a selective negative allosteric modulator of human α4β2 neuronal nicotinic receptorsCigarette smoking in iran.Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Bupropion for the treatment of nicotine withdrawal and craving.Current and emerging pharmacotherapies for treating tobacco dependence.A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea.Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimerasPotential therapeutic uses of mecamylamine and its stereoisomers.Mechanism-based medication development for the treatment of nicotine dependence.Disrupting nicotine reinforcement: from cigarette to brain.Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study.Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.Nicotinic receptor-based therapeutics and candidates for smoking cessation.Partial nicotinic acetylcholine (alpha4beta2) agonists as promising new medications for smoking cessation.
P2860
Q24202991-C8CFCDF1-5454-4075-B3EF-0F80611F21BCQ24203883-96BC46FA-8190-4FA3-88B4-DE32DEFED975Q24242851-AF93BF0F-1505-4BC3-8F31-2F081F9C2F25Q28206491-A195568E-6364-493D-A096-B68A9FE2A071Q28263028-F990E884-42C1-4332-B141-4F47E2AD2925Q28277165-D430A601-FE81-4F8C-B8F5-5AF91D3E3FFCQ30455930-12643C46-A3BA-4968-A3C8-75F877E0F034Q30491214-CB124236-7093-4295-B149-D1ECB91432C2Q33605582-6E6F6D9A-9EED-4857-8895-1D3BF74F988DQ33610442-4127913D-D28B-4307-9464-7B6F2D83617FQ33771975-9A65A7BA-7DAC-4952-B463-B5D0D2DBD627Q33908968-73D87B0E-8EB0-42D0-83D0-A3E919710ED6Q34401397-66C0E03A-3B24-4072-901F-605E8B1CDE75Q34470058-4C13F48E-72B1-4DDD-A98F-41C2C9449770Q34526371-DB399B71-76DC-4E93-AC8D-47D9882C30A3Q34805380-2842CAD1-7013-4CAD-9837-F9F5E1F3FB1CQ34953245-FD576433-B81B-4984-AD2F-06277EEF1327Q35429740-95A208E5-6AE8-42FA-9031-57BC28EB63D3Q35565775-13E90BDE-46AD-4D17-9313-8F834C1779E0Q35618971-AD882963-AEF3-4053-935D-908AE3BD07AEQ35684589-414AFC52-FCB7-4A15-A310-7B24C23870A0Q35742802-DA9EBDC5-E13D-4EB4-B7A2-76CA5027727FQ35975765-2FAA27A4-05AA-464E-87FE-716A6DE2285DQ36136238-4E4594A0-0EBF-46B8-BD49-AE62D92C7DBAQ36248558-25097B41-9A80-4D58-AA75-BB027890BE0DQ36348840-DDC377BB-063B-4AE7-9FB2-1413BBFC1375Q36372867-79A10043-03BE-4F92-A0D7-77F627F3F597Q36484647-6702635C-D17B-4B3D-8AE8-C0C6AEFE3054Q36511661-FFC98A19-1E8C-45A1-8416-D43012B73064Q36532139-F36BD262-091E-442A-A3F3-46C07D17DD5DQ36580581-4E1330C5-CC46-4466-8A64-2E099D6E22DCQ36746734-BB8298D3-B670-4740-BCAA-02818526F48FQ36807852-F81F3C4B-704B-4F65-B308-A6DF191EA777Q36949979-2B5D182C-584A-4421-B0DE-070361F1065BQ37018610-160A9EC1-44E0-4BC0-87FA-1DA44E9414B0Q37320728-64A7EA73-792E-4A7E-927F-5682E6A8E3CAQ37442261-EE7DCEB5-3373-4C3B-9D05-27AFBF83DD10Q37473457-B0CE99D5-F06F-437E-AC75-A373DFBCF6FCQ37518024-1004EF48-A0FF-448C-B772-CB92E8FA13D0Q37664482-66D0D0E1-7852-4DE0-A2A2-4FCCED089574
P2860
Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Mecamylamine combined with nic ...... icotine patch treatment alone.
@ast
Mecamylamine combined with nic ...... icotine patch treatment alone.
@en
Mecamylamine combined with nic ...... icotine patch treatment alone.
@nl
type
label
Mecamylamine combined with nic ...... icotine patch treatment alone.
@ast
Mecamylamine combined with nic ...... icotine patch treatment alone.
@en
Mecamylamine combined with nic ...... icotine patch treatment alone.
@nl
prefLabel
Mecamylamine combined with nic ...... icotine patch treatment alone.
@ast
Mecamylamine combined with nic ...... icotine patch treatment alone.
@en
Mecamylamine combined with nic ...... icotine patch treatment alone.
@nl
P2093
P356
P1476
Mecamylamine combined with nic ...... icotine patch treatment alone.
@en
P2093
P356
10.1038/CLPT.1994.105
P407
P577
1994-07-01T00:00:00Z